NCT07199101

Brief Summary

Children are sensitive to ionizing radiation, and there are significant regional variations in current pediatric CT radiation doses. Although there are studies on low-dose CT targeting single lesions, these studies require clear clinical indications and support from advanced equipment, making widespread promotion difficult. The establishment of low-dose CT protocols is mostly experience-based; when radiologists lack confidence in image quality, the credibility of diagnostic reports is compromised. Therefore, the development of low-dose protocols must meet the diagnostic confidence of most radiologists, enable clear visualization of key anatomical structures in clinical practice, and satisfy the requirements for disease diagnosis. The purpose of this study is to establish a pediatric low-dose CT scanning protocol using Low-dose Simulation of CT (LDS) technology, and conduct a multicenter randomized controlled trial (RCT) in clinical settings to verify the clinical feasibility of this low-dose CT scanning protocol.

Trial Health

63
Monitor

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Enrollment
2,650

participants targeted

Target at P75+ for not_applicable

Timeline
20mo left

Started Jan 2026

Typical duration for not_applicable

Geographic Reach
1 country

20 active sites

Status
not yet recruiting

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

Study Progress17%
Jan 2026Dec 2027

First Submitted

Initial submission to the registry

September 18, 2025

Completed
12 days until next milestone

First Posted

Study publicly available on registry

September 30, 2025

Completed
3 months until next milestone

Study Start

First participant enrolled

January 1, 2026

Completed
2 years until next milestone

Primary Completion

Last participant's last visit for primary outcome

December 31, 2027

Expected
Same day until next milestone

Study Completion

Last participant's last visit for all outcomes

December 31, 2027

Last Updated

September 30, 2025

Status Verified

September 1, 2025

Enrollment Period

2 years

First QC Date

September 18, 2025

Last Update Submit

September 22, 2025

Conditions

Keywords

Tomography, X-ray computedChildradiation dose

Outcome Measures

Primary Outcomes (1)

  • To evaluate the diagnostic performance of CT findings, including the concordance rate with pathological gold standards, other imaging modalities (e.g., MRI), or clinical diagnoses.

    With the clinical diagnosis (finally confirmed in pediatric patients after consultation, based on pathology, laboratory tests, other imaging examinations, and clinical characteristics) as the gold standard, determine the concordance rate between CT findings and clinical diagnoses.

    From enrollment to the end of treatment at 12 weeks

Secondary Outcomes (1)

  • To assess discrepancies in subjective image quality ratings among observers, using the Multi-Rater Concordance Correlation (MCRC) statistical method to evaluate the consistency of ratings across different observers.

    From enrollment to the end of treatment at 12 weeks

Study Arms (2)

Routine dose CT

NO INTERVENTION

Participants will undergo a routine dose CT adopting China's pediatric CT Diagnostic Reference Level protocol

Low dose CT

EXPERIMENTAL

Participants will undergo a low dose CT adopting the pediatric low-dose CT protocol established based on LDS

Radiation: Low dose CT

Interventions

Low dose CTRADIATION

Participants will undergo a low dose CT adopting the pediatric low-dose CT protocol established based on low dose simulation technique.

Low dose CT

Eligibility Criteria

Age0 Years - 18 Years
Sexall
Healthy VolunteersNo
Age GroupsChild (0-17), Adult (18-64)

You may qualify if:

  • Aged 0-17 years.
  • Pediatric patients for whom a CT examination is deemed necessary by an attending physician.

You may not qualify if:

  • Parents/guardians refuse to consent to low-dose CT examination.
  • Pediatric patients are in critical condition, with no time allocated for explanation of the randomized controlled trial (RCT) protocol.

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (20)

Beijing Children's Hospital, Capital Medical University, National Center for Children's Health

Beijing, Beijing Municipality, China

Location

Beijing Friendship Hospital, Capital Medical University

Beijing, Beijing Municipality, China

Location

Beijing Tongren Hospital, Capital Medical University

Beijing, Beijing Municipality, China

Location

Medical Center for Capital Children's Health, Capital Medical University

Beijing, Beijing Municipality, China

Location

National Institute for Radiological Protection, China CDC

Beijing, Beijing Municipality, China

Location

Peking Union Medical College Hospital

Beijing, Beijing Municipality, China

Location

Children's Hospital of Chongqing Medical University, National Clinical Research Center for Child Health and Disorders, Ministry of Education Key Laboratory of Child Development and Disorders.

Chongqing, Chongqing Municipality, China

Location

Guangdong Women and Children Hospital

Guangzhou, Guangdong, China

Location

Nanfang Hospital, Southern Medical University

Guangzhou, Guangdong, China

Location

Baoding Hospital, Beijing Children's Hospital Affiliated to Capital Medical University

Baoding, Heibei, China

Location

Fuwai Central China Cardiovascular Hospital

Zhengzhou, Henan, China

Location

The Third Affiliated Hospital of Zhengzhou University

Zhengzhou, Henan, China

Location

Affiliated Women's Hospital of Jiangnan University

Wuxi, Jiangsu, China

Location

Children's Hospital of Changchun

Changchun, Jilin, China

Location

the First Hospital of Jilin University

Changchun, Jilin, China

Location

The First Affiliated Hospital of Xi'an Jiao Tong University

Xi'an, Shaanxi, China

Location

Shanghai Children's Medical Center, School of Medicine

Shanghai, Shanghai Municipality, China

Location

Shanghai Jiao Tong University School of Medicine

Shanghai, Shanghai Municipality, China

Location

ShanghaiTech University

Shanghai, Shanghai Municipality, China

Location

People's Hospital of Xinjiang Uygur Autonomous Region

Ürümqi, Xinjiang, China

Location

Related Publications (2)

  • Xu H, Sun QF, Yue BR, Cheng JS, Niu YT. Results and analysis of examination doses for paediatric CT procedures based on a nationwide survey in China. Eur Radiol. 2024 Mar;34(3):1659-1666. doi: 10.1007/s00330-023-10005-7. Epub 2023 Sep 6.

    PMID: 37672054BACKGROUND
  • Bosch de Basea M, Thierry-Chef I, Harbron R, Hauptmann M, Byrnes G, Bernier MO, Le Cornet L, Dabin J, Ferro G, Istad TS, Jahnen A, Lee C, Maccia C, Malchair F, Olerud H, Simon SL, Figuerola J, Peiro A, Engels H, Johansen C, Blettner M, Kaijser M, Kjaerheim K, Berrington de Gonzalez A, Journy N, Meulepas JM, Moissonnier M, Nordenskjold A, Pokora R, Ronckers C, Schuz J, Kesminiene A, Cardis E. Risk of hematological malignancies from CT radiation exposure in children, adolescents and young adults. Nat Med. 2023 Dec;29(12):3111-3119. doi: 10.1038/s41591-023-02620-0. Epub 2023 Nov 9.

    PMID: 37946058BACKGROUND

Central Study Contacts

Study Design

Study Type
interventional
Phase
not applicable
Allocation
RANDOMIZED
Masking
TRIPLE
Who Masked
PARTICIPANT, CARE PROVIDER, OUTCOMES ASSESSOR
Purpose
DIAGNOSTIC
Intervention Model
PARALLEL
Model Details: On the RCT trial procedure, Participants will be randomly assigned to the intervention group (adopting the pediatric low-dose CT protocol established based on LDS) or the conventional CT dose group (adopting China's pediatric CT Diagnostic Reference Level protocol) at a 1:1 ratio. A statistician who is not directly involved in the analysis of study results or image evaluation will develop independent randomization schemes for each participating center using the randomized block design, so as to further reduce inter-center bias and ensure the concealment of the allocation scheme.
Sponsor Type
OTHER
Responsible Party
SPONSOR

Study Record Dates

First Submitted

September 18, 2025

First Posted

September 30, 2025

Study Start

January 1, 2026

Primary Completion (Estimated)

December 31, 2027

Study Completion (Estimated)

December 31, 2027

Last Updated

September 30, 2025

Record last verified: 2025-09

Locations